Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-20

FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil/amlodipine besylate/hydrochlorothiazide) from Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)